Biopharma Firm Alumis Shares Fall 20% After Downsized IPO - Bloomberg Law News

Retrieved on: 2024-06-28 17:46:08

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Firm Alumis Shares Fall 20% After Downsized IPO - Bloomberg Law News. View article details on hiswai:

Excerpt

Shares of Alumis Inc. sank 20% in the clinical stage biopharmaceutical company's public debut, after it raised $250 million in a downsized initial ...

Article found on: news.bloomberglaw.com

View Original Article